231 related articles for article (PubMed ID: 21266984)
1. High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke.
Campos F; Sobrino T; Ramos-Cabrer P; Castellanos M; Blanco M; Rodríguez-Yáñez M; Serena J; Leira R; Castillo J
J Cereb Blood Flow Metab; 2011 Jun; 31(6):1387-93. PubMed ID: 21266984
[TBL] [Abstract][Full Text] [Related]
2. Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels.
Campos F; Rodríguez-Yáñez M; Castellanos M; Arias S; Pérez-Mato M; Sobrino T; Blanco M; Serena J; Castillo J
Clin Sci (Lond); 2011 Jul; 121(1):11-7. PubMed ID: 21265738
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study.
Campos F; Sobrino T; Ramos-Cabrer P; Argibay B; Agulla J; Pérez-Mato M; Rodríguez-González R; Brea D; Castillo J
J Cereb Blood Flow Metab; 2011 Jun; 31(6):1378-86. PubMed ID: 21266983
[TBL] [Abstract][Full Text] [Related]
4. Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke.
Hervella P; Sampedro-Viana A; Fernández-Rodicio S; Rodríguez-Yáñez M; López-Dequidt I; Pumar JM; Mosqueira AJ; Bazarra-Barreiros M; Abengoza-Bello MT; Ortega-Espina S; Ouro A; Pérez-Mato M; Campos F; Sobrino T; Castillo J; Alonso-Alonso ML; Iglesias-Rey R
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928260
[TBL] [Abstract][Full Text] [Related]
5. Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke.
Khanna S; Stewart R; Gnyawali S; Harris H; Balch M; Spieldenner J; Sen CK; Rink C
FASEB J; 2017 Oct; 31(10):4533-4544. PubMed ID: 28655710
[TBL] [Abstract][Full Text] [Related]
6. Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients.
Campos F; Sobrino T; Pérez-Mato M; Rodríguez-Osorio X; Leira R; Blanco M; Mirelman D; Castillo J
Cephalalgia; 2013 Oct; 33(14):1148-54. PubMed ID: 23674828
[TBL] [Abstract][Full Text] [Related]
7. Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke.
Khanna S; Briggs Z; Rink C
Antioxid Redox Signal; 2015 Jan; 22(2):175-86. PubMed ID: 25343301
[TBL] [Abstract][Full Text] [Related]
8. GOT to rid the body of excess glutamate.
Teichberg VI
J Cereb Blood Flow Metab; 2011 Jun; 31(6):1376-7. PubMed ID: 21448218
[No Abstract] [Full Text] [Related]
9. Potential protective role of endogenous glutamate-oxaloacetate transaminase against glutamate excitotoxicity in fetal hypoxic-ischaemic asphyxia.
Pérez-Mato M; Iglesias-Deus A; Rujido S; da Silva-Candal A; Sobrino T; Couce ML; Fraga JM; Castillo J; Campos F
Dev Med Child Neurol; 2016 Jan; 58(1):57-62. PubMed ID: 26205194
[TBL] [Abstract][Full Text] [Related]
10. Oxygen-inducible glutamate oxaloacetate transaminase as protective switch transforming neurotoxic glutamate to metabolic fuel during acute ischemic stroke.
Rink C; Gnyawali S; Peterson L; Khanna S
Antioxid Redox Signal; 2011 May; 14(10):1777-85. PubMed ID: 21361730
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naïve rats.
Boyko M; Stepensky D; Gruenbaum BF; Gruenbaum SE; Melamed I; Ohayon S; Glazer M; Shapira Y; Zlotnik A
Neurochem Res; 2012 Oct; 37(10):2198-205. PubMed ID: 22846966
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of glutamate during stroke is associated with development of post-stroke depression.
Cheng SY; Zhao YD; Li J; Chen XY; Wang RD; Zeng JW
Psychoneuroendocrinology; 2014 Sep; 47():126-35. PubMed ID: 25001962
[TBL] [Abstract][Full Text] [Related]
13. Oxaloacetate: a novel neuroprotective for acute ischemic stroke.
Campos F; Sobrino T; Ramos-Cabrer P; Castillo J
Int J Biochem Cell Biol; 2012 Feb; 44(2):262-5. PubMed ID: 22085530
[TBL] [Abstract][Full Text] [Related]
14. Relationship between glutamate, GOT and GPT levels in maternal and fetal blood: a potential mechanism for fetal neuroprotection.
Zlotnik A; Tsesis S; Gruenbaum BF; Ohayon S; Gruenbaum SE; Boyko M; Sheiner E; Brotfain E; Shapira Y; Teichberg VI
Early Hum Dev; 2012 Sep; 88(9):773-8. PubMed ID: 22633534
[TBL] [Abstract][Full Text] [Related]
15. Determination of factors affecting glutamate concentrations in the whole blood of healthy human volunteers.
Zlotnik A; Ohayon S; Gruenbaum BF; Gruenbaum SE; Mohar B; Boyko M; Klin Y; Sheiner E; Shaked G; Shapira Y; Teichberg VI
J Neurosurg Anesthesiol; 2011 Jan; 23(1):45-9. PubMed ID: 21248494
[TBL] [Abstract][Full Text] [Related]
16. Glutamate oxaloacetate transaminase enables anaplerotic refilling of TCA cycle intermediates in stroke-affected brain.
Rink C; Gnyawali S; Stewart R; Teplitsky S; Harris H; Roy S; Sen CK; Khanna S
FASEB J; 2017 Apr; 31(4):1709-1718. PubMed ID: 28096234
[TBL] [Abstract][Full Text] [Related]
17. Blood Glutamate Reducing Effect of Hemofiltration in Critically Ill Patients.
Brotfain E; Kutz R; Grinshpun J; Gruenbaum BF; Gruenbaum SE; Frenkel A; Zhumadilov A; Zeldetz V; Bichovsky Y; Boyko M; Klein M; Zlotnik A
Neurotox Res; 2018 Feb; 33(2):300-308. PubMed ID: 28836163
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage.
Dopico-López A; Pérez-Mato M; da Silva-Candal A; Iglesias-Rey R; Rabinkov A; Bugallo-Casal A; Sobrino T; Mirelman D; Castillo J; Campos F
Transl Res; 2021 Apr; 230():68-81. PubMed ID: 33132087
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke.
Boyko M; Zlotnik A; Gruenbaum BF; Gruenbaum SE; Ohayon S; Kuts R; Melamed I; Regev A; Shapira Y; Teichberg VI
Eur J Neurosci; 2011 Nov; 34(9):1432-41. PubMed ID: 21936878
[TBL] [Abstract][Full Text] [Related]
20. The effects of hemodialysis on blood glutamate levels in chronic renal failure: implementation for neuroprotection.
Rogachev B; Ohayon S; Saad A; Vorobiovsky V; Gruenbaum BF; Leibowitz A; Boyko M; Shapira Y; Shnaider A; Zlotnik M; Azab AN; Zlotnik A
J Crit Care; 2012 Dec; 27(6):743.e1-7. PubMed ID: 23084134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
